Trial Site Detail

 

Drug:
ARQ 092
Trial:
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Site name unknown, Lafayette, IN 47905

     
Lafayette , IN 47905
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown, Lafayette, IN 47905 Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.